The Role of Exosomes in Pancreatic Cancer Microenvironment

[1]  F. Jiang,et al.  Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia , 2015, PloS one.

[2]  Jian Chen,et al.  Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p , 2015, Oncotarget.

[3]  Lijun Wu,et al.  Exosomes in cancer: small particle, big player , 2015, Journal of Hematology & Oncology.

[4]  L. Benesova,et al.  MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis , 2015, Gastroenterology research and practice.

[5]  Zhong Wang,et al.  miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2 , 2015, Diagnostic Pathology.

[6]  I. D'Agnano,et al.  Signaling by exosomal microRNAs in cancer , 2015, Journal of experimental & clinical cancer research : CR.

[7]  Sha Li,et al.  Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..

[8]  Yanmei Xu,et al.  Exosomes: Novel Biomarkers for Clinical Diagnosis , 2015, TheScientificWorldJournal.

[9]  J. Inal,et al.  Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis , 2015, Journal of extracellular vesicles.

[10]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[11]  Min Zhou,et al.  Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. , 2014, Cellular immunology.

[12]  A. Friedman,et al.  Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis , 2014, PloS one.

[13]  A. Friedman,et al.  Mathematical model of sarcoidosis , 2014, Proceedings of the National Academy of Sciences.

[14]  Gisele Monteiro,et al.  Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. , 2014, European journal of pharmacology.

[15]  M. Marks,et al.  TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation , 2014, Proceedings of the National Academy of Sciences.

[16]  Muneesh Tewari,et al.  Quantitative and stoichiometric analysis of the microRNA content of exosomes , 2014, Proceedings of the National Academy of Sciences.

[17]  S. Esener,et al.  TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant , 2014, Journal of Translational Medicine.

[18]  Avner Friedman,et al.  Mathematical Modeling of Interleukin-27 Induction of Anti-Tumor T Cells Response , 2014, PloS one.

[19]  Avner Friedman,et al.  The LDL-HDL Profile Determines the Risk of Atherosclerosis: A Mathematical Model , 2014, PloS one.

[20]  Elaine C. Campbell,et al.  Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway. , 2014, European journal of cancer.

[21]  Haichao Wang,et al.  The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics , 2014, Oncogene.

[22]  S. Bojesen,et al.  MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.

[23]  M. Zöller.  Pancreatic cancer diagnosis by free and exosomal miRNA. , 2013, World journal of gastrointestinal pathophysiology.

[24]  Stefano Fais,et al.  Exosomes: the future of biomarkers in medicine. , 2013, Biomarkers in medicine.

[25]  L. Buscail,et al.  Targeting miR-21 for the therapy of pancreatic cancer. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  H. Baba,et al.  Clinical impact of serum exosomal microRNA‐21 as a clinical biomarker in human esophageal squamous cell carcinoma , 2013, Cancer.

[27]  C. Celik-Ozenci,et al.  Role of TNF-related apoptosis-inducing ligand (TRAIL) in the pathogenesis of varicocele-induced testicular dysfunction. , 2013, Asian journal of andrology.

[28]  T. Whiteside.  Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). , 2013, Biochemical Society transactions.

[29]  G. Shurin,et al.  Dendritic Cells in the Cancer Microenvironment , 2012, Journal of Cancer.

[30]  V. Akatov,et al.  Increase in resistance of A431 cancer cells to TRAIL-induced apoptosis in confluent cultures , 2012, Biofizika.

[31]  William J. Buchser,et al.  Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands , 2012, Oncoimmunology.

[32]  M. Kesimer,et al.  Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. , 2012, Analytical biochemistry.

[33]  N. Lagali,et al.  Pathologic epithelial and anterior corneal nerve morphology in early-stage congenital aniridic keratopathy. , 2012, Ophthalmology.

[34]  A. Friedman,et al.  Modeling the inhibition of breast cancer growth by GM-CSF. , 2012, Journal of theoretical biology.

[35]  Yu-rong Shi,et al.  MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells , 2012, Journal of Experimental & Clinical Cancer Research.

[36]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[37]  M. Kasper,et al.  MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma , 2012, Oncogenesis.

[38]  N. Rothman,et al.  Decreased Numbers of CD4+ Naive and Effector Memory T Cells, and CD8+ Naïve T Cells, are Associated with Trichloroethylene Exposure , 2012, Front. Oncol..

[39]  A. Bader,et al.  Developing therapeutic microRNAs for cancer , 2011, Gene Therapy.

[40]  R. Ray,et al.  Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity. , 2011, Genes & cancer.

[41]  D. Ichikawa,et al.  Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma , 2011, British Journal of Cancer.

[42]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[43]  James J. Campbell,et al.  Resident Memory T Cells (TRM) Are Abundant in Human Lung: Diversity, Function, and Antigen Specificity , 2011, PloS one.

[44]  K. Ohuchida,et al.  MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma , 2010, Annals of Surgical Oncology.

[45]  N. Müller,et al.  Superior serum half life of albumin tagged TNF ligands. , 2010, Biochemical and biophysical research communications.

[46]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[47]  Y. Yuasa,et al.  miR‐212 is downregulated and suppresses methyl‐CpG‐binding protein MeCP2 in human gastric cancer , 2009, International journal of cancer.

[48]  Hiroyuki Suzuki,et al.  Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. , 2010, The Journal of investigative dermatology.

[49]  Herbert J Zeh,et al.  High-mobility group box 1 and cancer. , 2010, Biochimica et biophysica acta.

[50]  Lei Han,et al.  MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol , 2010, BMC Cancer.

[51]  Avner Friedman,et al.  Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.

[52]  Douglas D. Taylor,et al.  Exosomal microRNA: a diagnostic marker for lung cancer. , 2008, Clinical lung cancer.

[53]  E. Hiltbold,et al.  IL-12 Produced by Dendritic Cells Augments CD8+ T Cell Activation through the Production of the Chemokines CCL1 and CCL171 , 2008, The Journal of Immunology.

[54]  C. Tepper,et al.  microRNAs and prostate cancer , 2008, Journal of cellular and molecular medicine.

[55]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[56]  E. Solary,et al.  TRAIL in cancer therapy: present and future challenges , 2007, Expert opinion on therapeutic targets.

[57]  Herbert J. Zeh,et al.  Masquerader: High Mobility Group Box-1 and Cancer , 2007, Clinical Cancer Research.

[58]  F. Tas,et al.  Serum IL-8 and IL-12 levels in breast cancer , 2007, Medical oncology.

[59]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[60]  J. Pilch,et al.  [Interleukin 2 concentration changes in the laryngeal cancer patients during the surgical treatment]. , 2006, Otolaryngologia polska = The Polish otolaryngology.

[61]  D. Whitcomb.  Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[62]  H. Bozkurt,et al.  Change in Serum Concentrations of Interleukin-2 and Interferon-γ during Treatment of Tuberculosis , 2004, The Journal of international medical research.

[63]  S. Sheen-Chen,et al.  Serum concentration of tumor necrosis factor in patients with breast cancer , 1997, Breast Cancer Research and Treatment.

[64]  Y. Sharma,et al.  Vascular endothelial growth factor expression and signaling in the lens. , 2003, Investigative ophthalmology & visual science.

[65]  M. Cosio,et al.  Inflammation of the airways and lung parenchyma in COPD: role of T cells. , 2002, Chest.

[66]  D. Hart,et al.  Dendritic cell density and activation status in human breast cancer – CD1a, CMRF-44, CMRF-56 and CD-83 expression , 2002, British Journal of Cancer.

[67]  Steven G. Deeks,et al.  Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans , 1999, Nature Medicine.

[68]  C. Atkinson,et al.  Minimal recruitment and activation of dendritic cells within renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  M S Favero,et al.  Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. , 1993, Lymphokine and cytokine research.

[70]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[71]  P. Carroad,et al.  Estimation of diffusion coefficients of proteins , 1980 .